Formulation Change for Pancrelipaze-R. Container Closure Change for Pancrelipaze-R — critical change. Impacts 3 markets and 2 variations.

Change Number
CHG-2021-0168
Type
Formulation Change
Status
Submitted
Owner
Dmitri Volkov
Initiated
2022-04-08
Description

Container Closure Change for Pancrelipaze-R — critical change

Impacted Markets (3)
IT — ItalyTR — TurkeyDK — Denmark
Impacted Modules
3.2.P.3
Linked Variations (0)
Variation #TypeApplicationStatusSubmittedApproved